Resistance to asbestos-induced apoptosis with continuous exposure to crocidolite on a human T cell

Science of the Total Environment

Volumn 429, Issue , 2012, Pages 174-182

  Maeda, Megumi ^a,b   Yamamoto, Shoko ^b   Chen, Ying ^c   Kumagai Takei, Naoko ^b   Hayashi, Hiroaki ^b   Matsuzaki, Hidenori ^b   Lee, Suni ^b   Hatayama, Tamayo ^b   Miyahara, Naomi ^b   Katoh, Minako ^b   Hiratsuka, Juni ichi ^b   Nishimura, Yasumitsu ^b   Otsuki, Takemi ^b  

^a OKAYAMA UNIVERSITY   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

^c CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Asbestos; Chrysotile; Crocidolite; T cell

Indexed keywords

ASBESTOS EXPOSURE; ASBESTOS-RELATED DISEASE; CARCINOGENIC ACTIVITY; CDNA MICROARRAYS; CHEMOKINE RECEPTORS; CHEMOPREVENTION; CHRYSOTILE; CLINICAL TOOLS; CONTINUOUS EXPOSURE; CROCIDOLITE; GROWTH INHIBITION; HUMAN T CELLS; IMMUNOLOGICAL EFFECTS; LOW DOSE; REDUCED PRODUCTION; SIMILAR DEGREE; T CELLS; TRANSIENT EXPOSURE; UP-REGULATION;

CARCINOGENS; CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CHEMICAL DETECTION; DRUG PRODUCTS; ELECTRIC LOAD MANAGEMENT; FACTOR ANALYSIS; SERPENTINE; TRANSCRIPTION FACTORS; TUMORS;

ASBESTOS;

ASBESTOS; CHEMOKINE RECEPTOR CXCR3; CHRYSOTILE; COMPLEMENTARY DNA; CROCIDOLITE; GAMMA INTERFERON; INTERLEUKIN 10; PROTEIN BAX; PROTEIN BCL 2; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ASBESTOS; CARCINOGEN; CELL ORGANELLE; DNA; IMMUNITY;

APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA MICROARRAY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNITY; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNITY; UPREGULATION;

APOPTOSIS; ASBESTOS, CROCIDOLITE; CELL LINE, TRANSFORMED; CYTOKINES; HUMANS; REACTIVE OXYGEN SPECIES; T-LYMPHOCYTES;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 84862250710     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2012.04.043     Document Type: Article

References (27)

1. Craighead J.E., Gibbs A., Pooley F. Mineralogy of asbestos. Asbestos and its diseases 2008, 23-38. Oxford University Press, New York. J.E. Craighead, A.R. Gibbs (Eds.).
2. Hyodoh F., Takata-Tomokuni A., Miura Y., Sakaguchi H., Hatayama T., Hatada S., et al. Inhibitory effects of anti-oxidants on apoptosis of a human polyclonal T-cell line, MT-2, induced by an asbestos, chrysotile-A. Scand J Immunol 2005, 61:442-448.
3. Kamp D.W., Graceffa P., Pryor W.A., Weitzman S.A. The role of free radicals in asbestos-induced diseases. Free Radic Biol Med 1992, 12:293-315.
4. Kohyama N., Shinohara Y., Suzuki Y. Mineral phases and some reexamined characteristics of the International Union Against Cancer standard asbestos samples. Am J Ind Med 1996, 30:515-528.
5. Kurumatani N., Kumagai S. Mapping the risk of mesothelioma due to neighborhood asbestos exposure. Am J Respir Crit Care Med 2008, 178:624-629.
6. Lemen R.A. Epidemiology of asbestos-related diseases and the knowledge that led to what is known today. Asbestos: risk assessment, epidemiology, and health effects 2006, 201-308. Taylor & Francis Group, CRC Press, Boca Raton, FL. R.F. Dodson, S.P. Hammar (Eds.).
7. Maeda M., Nishimura Y., Kumagai N., Hayashi H., Hatayama T., Katoh M., et al. Dysregulation of the immune system caused by silica and asbestos. J Immunotoxicol 2010, 7:268-278.
8. Maeda M., Nishimura Y., Hayashi H., Kumagai N., Chen Y., Murakami S., et al. Reduction of CXC chemokine receptor 3 in an in vitro model of continuous exposure to asbestos in a human T-cell line, MT-2. Am J Respir Cell Mol Biol 2011, 45:470-479.
9. Maeda M., Nishimura Y., Hayashi H., Kumagai N., Chen Y., Murakami S., et al. Decreased CXCR3 expression in CD4+ T cells exposed to asbestos or derived from asbestos-exposed patients. Am J Respir Cell Mol Biol 2011, Feb 25 [Epub ahead of print].
10. Matsuzaki H., Maeda M., Lee S., Nishimura Y., Kumagai-Takei N., Hayashi H., et al. Asbestos-induced cellular and molecular alteration of immunocompetent cells and the relationship with chronic inflammation and carcinogenesis. J Biomed Biotechnol 2012, Article ID 492608. 10.1155/2012/492608.
11. Miura Y., Nishimura Y., Katsuyama H., Maeda M., Hayashi H., Dong M., et al. Involvement of IL-10 and Bcl-2 in resistance against an asbestos-induced apoptosis of T cells. Apoptosis 2006, 11:1825-1835.
12. Miura Y., Nishimura Y., Maeda M., Murakami S., Hayashi H., Fukuoka K., et al. Immunological alterations found in mesothelioma patients and supporting experimental evidence. Environ Health Prev Med 2008, 13:55-59.
13. Miyoshi I., Kubonishi I., Yoshimoto S., Akagi T., Ohtsuki Y., Shiraishi Y., et al. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 1981, 294:770-771.
14. Murakami S., Nishimura Y., Maeda M., Kumagai N., Hayashi H., Chen Y., et al. Cytokine alteration and speculated immunological pathophysiology in silicosis and asbestos-related diseases. Environ Health Prev Med 2009, 14:216-222.
15. Nagai H., Toyokuni S. Biopersistent fiber-induced inflammation and carcinogenesis: lessons learned from asbestos toward safety of fibrous nanomaterials. Arch Biochem Biophys 2010, 502:1-7.
16. Nishimura Y., Miura Y., Maeda M., Kumagai N., Murakami S., Hayashi H., et al. Impairment in cytotoxicity and expression of NK cell- activating receptors on human NK cells following exposure to asbestos fibers. Int J Immunopathol Pharmacol 2009, 22:579-590.
17. Nishimura Y., Maeda M., Kumagai N., Hayashi H., Miura Y., Otsuki T. Decrease in phosphorylation of ERK following decreased expression of NK cell-activating receptors in human NK cell line exposed to asbestos. Int J Immunopathol Pharmacol 2009, 22:879-888.
18. Nishimura Y., Kumagai N., Maeda M., Hayashi H., Fukuoka K., Nakano T., et al. Suppressive effect of asbestos on cytotoxicity of human NK cells. Int J Immunopathol Pharmacol 2011, 24(1 Suppl.):5S-10S.
19. Otsuki T., Maeda M., Murakami S., Hayashi H., Miura Y., Kusaka M., et al. Immunological effects of silica and asbestos. Cell Mol Immunol 2007, 4:261-268.
20. Otsuki T., Maeda M., Miura Y., Hayashi H., Murakami S., Kumagai N., et al. Immunological effects of asbestos. Asbestos: risks, environment and impact 2009, 185-193. Nova Science Publishers, Inc., New York. A. Soto, G. Salazar (Eds.).
21. Otsuki T., Hayashi H., Nishimura Y., Hyodo F., Maeda M., Kumagai N., et al. Dysregulation of autoimmunity caused by silica exposure and alteration of Fas-mediated apoptosis in T lymphocytes derived from silicosis patients. Int J Immunopathol Pharmacol 2011, 24(1 Suppl.):11S-16S.
22. Rappaport E. Asbestos litigation: prospects for legislative resolution. Asbestos: risks, environment and impact 2009, 137-151. Nova Science Publishers, Inc., New York. A. Soto, G. Salazar (Eds.).
23. Roggli V.L., Coin P. Mineralogy of asbestos. Asbestos-associated diseases 2004, 1-16. Springer Science+Business Media, Inc., New York. 2nd Edition. V.L. Roggli, T.D. Oury, T.A. Sporn (Eds.).
24. Rolston R., Oury T.D. Other neoplasia. Asbestos-associated diseases 2004, 193-216. Springer Science+Business Media, Inc., New York. 2nd Edition. V.L. Roggli, T.D. Oury, T.A. Sporn (Eds.).
25. Toyokuni S. Role of iron in carcinogenesis: cancer as a ferrotoxic disease. Cancer Sci 2009, 100:9-16.
26. Upadhyay D., Kamp D.W. Asbestos-induced pulmonary toxicity: role of DNA damage and apoptosis. Exp Biol Med (Maywood) 2003, 28:650-659.
27. Virta R.L. U.S. Geological Survey - mineral information 2010, http://minerals.usgs.gov/minerals/pubs/commodity/asbestos/myb1-2010-asbes.pdf.